Paper42909264PubMed
DYRK1A - a gene dose paradox.
Plećaš A and 6 others. Front Cell Dev Biol, 2026.
Cite this record
ConductScience Library. DYRK1A - a gene dose paradox. Papers, record 42909264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42909264
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DYRK1A - a gene dose paradox.
- Journal
- Front Cell Dev Biol
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-25
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31237416 | Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21. | Mol Genet Genomic Med | 2019 | https://conductscience.org/library/papers/31237416 | PubMed |
| 2 | 33159716 | DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature. | Mol Genet Genomic Med | 2020 | https://conductscience.org/library/papers/33159716 | PubMed |
| 3 | 39397076 | Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells. | Sci Rep | 2024 | https://conductscience.org/library/papers/39397076 | PubMed |
| 4 | 42168793 | Age-related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndrome. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42168793 | PubMed |
| 5 | 18771760 | DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. | Am J Hum Genet | 2008 | https://conductscience.org/library/papers/18771760 | PubMed |
| 6 | 42501327 | A Researcher's guide to rodent models of Down syndrome: Recent insights and translational perspectives. | STAR Protoc | 2026 | https://conductscience.org/library/papers/42501327 | PubMed |
| 7 | 7550346 | A mouse model for Down syndrome exhibits learning and behaviour deficits. | Nat Genet | 1995 | https://conductscience.org/library/papers/7550346 | PubMed |
| 8 | 23413375 | Concise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease. | Stem Cells Transl Med | 2013 | https://conductscience.org/library/papers/23413375 | PubMed |
| 9 | 40505942 | The role of Goldilocks protein kinase DYRK1A in embryonic development. | Dev Biol | 2025 | https://conductscience.org/library/papers/40505942 | PubMed |
| 10 | 42367034 | Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/42367034 | PubMed |
| 11 | 22293606 | DYRK1A: a master regulatory protein controlling brain growth. | Neurobiol Dis | 2012 | https://conductscience.org/library/papers/22293606 | PubMed |
| 12 | 19002211 | Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. | Eur J Hum Genet | 2009 | https://conductscience.org/library/papers/19002211 | PubMed |
| 13 | 36544206 | Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype association. | BMC Med Genomics | 2022 | https://conductscience.org/library/papers/36544206 | PubMed |
| 14 | 25694335 | Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration. | Stem Cells | 2015 | https://conductscience.org/library/papers/25694335 | PubMed |
| 15 | 30619508 | Down syndrome phenotype in a boy with a mosaic microduplication of chromosome 21q22. | Mol Cytogenet | 2018 | https://conductscience.org/library/papers/30619508 | PubMed |
| 16 | 37451904 | Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels. | EBioMedicine | 2023 | https://conductscience.org/library/papers/37451904 | PubMed |
| 17 | 28377597 | Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice. | Sci Rep | 2017 | https://conductscience.org/library/papers/28377597 | PubMed |
| 18 | 30979931 | A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response. | Sci Rep | 2019 | https://conductscience.org/library/papers/30979931 | PubMed |
| 19 | 18509201 | Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. | FASEB J | 2008 | https://conductscience.org/library/papers/18509201 | PubMed |
| 20 | 26137553 | DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome. | EBioMedicine | 2015 | https://conductscience.org/library/papers/26137553 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42909264
GET https://conductscience.org/api/papers/v1/42909264/references?page=2